Cinnamon and blood sugar: what the research actually says

Two different barks, one word

Cinnamon is not one plant. The word covers several closely related trees whose inner bark is dried and sold under the same name, and the two that matter for supplements behave differently.

Cassia cinnamon, Cinnamomum aromaticum, is grown in areas of southeastern Asia and is, in NIH’s words, the most common type sold in North America. Ceylon cinnamon, Cinnamomum verum, is the other, and NIH says it grows primarily in Sri Lanka.

The distinction almost never appears in marketing copy, which talks about cinnamon as though the word settled the question. It does not. Two products can both say cinnamon on the front and contain materially different barks, and the Supplement Facts panel is the only place the botanical source gets printed.

The coumarin question

The reason the species matters is a compound called coumarin, which occurs naturally in cinnamon bark in very different quantities depending on which bark you started with.

NIH puts it plainly: interactions between coumarin and the liver have been reported, ordinary cassia use does not usually carry enough coumarin to cause significant problems, but some cassia products contain high levels, and prolonged use could be an issue for sensitive people such as those with liver disease. Ceylon may contain a trace amount. That is why the distinction gets raised in the context of daily supplementation rather than a teaspoon on porridge. A pinch in food and a gram or more every day for months are different propositions, and the second is what a supplement proposes.

None of that makes cassia dangerous at the amounts most people eat, and none of it makes Ceylon effective. It is a reason to know which one you are taking. If a label prints only the word cinnamon with no species, you are being asked to assume.

Why “cinnamon is in it” tells you nothing

Which brings us to the sentence this article exists to argue with: it has cinnamon in it.

That sentence contains no dose, and without a dose it carries almost no information. Cinnamon at 1,000 mg a day is the ingredient the 2019 review was looking at. Cinnamon at 20 mg a day is a flavour note. Both are truthfully described as having cinnamon in them, both can print the same word on the front of the bottle, and only one of them is in the neighbourhood of anything that was studied.

This is exactly the gap a proprietary blend leaves open. When cinnamon sits inside a blend declared as a single total, the label names it without quantifying it, and the buyer is left to assume. Assumptions in this direction are usually generous.

So the question to ask is never whether a product contains cinnamon. It is how many milligrams a daily serving delivers, and whether the label answers that at all.

Where cinnamon sits against what actually moves numbers

It is also worth keeping the ingredient in proportion. The CDC’s guidance on preventing type 2 diabetes is built on weight, physical activity and structured programmes rather than on anything swallowed from a bottle, and prediabetes is common enough that this guidance is aimed at a very large number of adults.

That is not an argument that cinnamon is worthless. It is an argument about order. The interventions with the strongest evidence behind them are free, unglamorous and almost never advertised, because nobody has a margin to spend on advertising them. A supplement can sit on top of them. It is a poor substitute for them.

The one genuinely serious mistake in this area is quiet: someone starts a supplement, feels reassured, and drifts away from a prescription or a follow-up appointment. Nobody decides to do that. It happens by degrees, and telling a clinician what you have started is a one-sentence protection against it.

The bottom line

Cinnamon has the strongest published signal of any botanical in this blend, and the evidence sits at doses measured in grams, from studies that differed in strength of dose, length of treatment and type of participant. NIH’s own conclusion is blunter than the marketing: it is unclear whether cinnamon supplementation is helpful for diabetes or weight loss, and higher quality research would be needed to clarify any benefit.

Two questions get you most of the way through any cinnamon product. Which bark is it, which a good label answers with a botanical name. And how many milligrams are in a daily serving, which a blend does not answer at all.

On this one the first question is answered and the second is not. Read the panel, ask for the amount, and keep taking whatever a clinician prescribed you.